The current diagnostic standard procedure outlined by the Health Protection Agency for urinary tract infections (UTIs) in clinical laboratories does not report bacteria isolated from samples containing three or more different bacterial species. As a result many UTIs go unreported and untreated, particularly in elderly patients, where polymicrobial UTI samples are especially prevalent. This study reports the presence of the major uropathogenic species in mixed culture urine samples from elderly patients, and of resistance to front-line antibiotics, with potentially increased levels of resistance to ciprofloxacin and trimethoprim. Most importantly, the study highlights that Escherichia coli present in polymicrobial UTI samples are statistically more invasive (P,0.001) in in vitro epithelial cell infection assays than those isolated from monomicrobial culture samples. In summary, the results of this study suggest that the current diagnostic standard procedure for polymicrobial UTI samples needs to be reassessed, and that E. coli present in polymicrobial UTI samples may pose an increased risk to human health.
INTRODUCTION
The annual incidence of urinary tract infections (UTIs) in the elderly population ranges from 10 % in the community to as high as 30 % of hospitalized patients (Cove-Smith & Almond, 2007) . Mortality rates in elderly patients from bacteraemia as a result of UTI can be as high as 33 % (Tal et al., 2005) . A study by Plowman et al. (2001) found that over a 12 month period UTIs had the highest incidence (35 %) of all nosocomial infections in a district general hospital, and the majority of patients were over 60 years of age. UTIs are also the most common infection in long-term care facilities, where they account for 20-60 % of all antibiotic prescription use (Nicolle, 2001a) . This large-scale prescription of antibiotics may well contribute to the levels of antibiotic resistance in urinary pathogens (Zhanel et al., 2005) . The main aetiological agent of UTIs is well documented as Escherichia coli (Nicolle, 2001b; Farajnia et al., 2009; Kumazawa & Matsumoto, 1997) . The establishment of urinary tract pathogens is thought to begin with the invasion of the superficial bladder epithelium, where bacteria can form intracellular communities and receive a level of protection against the host immune system and antibiotic treatment (Anderson et al., 2003; Blango & Mulvey, 2010) .
The diagnosis of UTI is routinely made in the clinical laboratory by microbiological culture of a urine sample according to the national standard method developed and approved by the Health Protection Agency (HPA) (http:// www.hpa-standardmethods.org.uk/documents/bsop/pdf/ bsop41.pdf). Infections caused by a single organism are usually treatable with an antibiotic regimen advised on the basis of antibiotic susceptibility tests. However, it has been estimated that 33 % of urine cultures from elderly patients are polymicrobial (Cove-Smith & Almond, 2007) . Due to the difficulties of identifying the organisms present in these cultures, clinical microbiology laboratories do not report organisms isolated from urine in mixed cultures unless there is a significant count of a predominant organism.
As a result there is insufficient information on the bacteria that cause polymicrobial UTIs and the threat they pose to patient health. This study aimed to isolate the organisms present in polymicrobial UTI samples from a population of elderly patients, and compare their prevalence, phenotypic activity and pathogenic potential to monomicrobial culture isolates from the same population, with the aim of further understanding the potential threat posed by bacteria present in polymicrobial urine samples from elderly patients, and possibly reassessing the current diagnostic standard procedure.
METHODS
Sample collection. A total of 250 urine culture agar plates were collected from Nottingham University Hospitals (NUH) between October 2008 and June 2009. Cultures were collected anonymously (therefore no ethical approval or informed consent was required) from patients aged 70 and over, and assigned to one of the following categories: (i) non-catheterized male polymicrobial infection, (ii) non-catheterized female polymicrobial infection, (iii) catheterized male polymicrobial infection, (iv) catheterized female polymicrobial infection. All of the categories contained cultures with three or more organisms and with no predominant count of one species. A fifth group, monomicrobial infection (uncatheterized or catheterized, males or females), was also included for use as a control group. Bacteria were isolated using standard microbiological identification procedures. Identification of isolates to the species level was performed using API identification systems, API 20E, API 20strep, API 20NE and API Staph (bioMérieux).
Antibiotic susceptibility testing. A breakpoint method was employed to obtain antibiotic susceptibility profiles for all E. coli, Staphylococcus aureus, Enterococcus faecalis and Proteus mirabilis. The British Society for Antimicrobial Chemotherapy (BSAC) method for antimicrobial susceptibility testing was followed for preparing standardized inocula (Andrews, 2009 ). All Pseudomonas aeruginosa isolates were tested using the BSAC disc diffusion method (Andrews, 2009) ) and ciprofloxacin (1 mg ml
21
).
PCR detection of b-lactamase-encoding genes. All E. coli, Klebsiella, Proteus, Pseudomonas, Enterobacter and Citrobacter isolates were tested for the presence of the b-lactamase-encoding genes, bla TEM , bla SHV , bla CTX-M and bla OXA using a published multiplex PCR assay (Fang et al., 2008) . GenElute extraction kits (Sigma) were used to extract bacterial genomic DNA. Reference strains containing known b-lactamase types (NCTC 13351 E. coli bla TEM-3 , NCTC 13353 E. coli bla OXA , bla CTX-M-15 and bla TEM , and NCTC 13368 Klebsiella pneumoniae bla TEM , bla SHV-18 ) were included as controls.
Extended-spectrum b-lactamase (ESBL) confirmation tests.
ESBL combination identification discs were used to confirm the extended-spectrum activity of selected b-lactamase-positive strains. The BSAC method for antimicrobial susceptibility testing (Andrews, 2009) was followed for preparing a standardized inoculum, which was used to inoculate an Iso-Sensitest agar plate to produce a lawn of growth. Two sets of combination discs were used to optimize ESBL detection: cefpodoxime/cefpodoxime and clavulanic acid, and cefepime/cefepime and clavulanic acid. An increase in the diameter of the zone of inhibition of ¢5 mm for the cephalosporin/clavulanic acid disc compared to the cephalosporin alone disc indicated the presence of an ESBL-producing organism. Reference organisms E. coli NCTC 13351, E. coli NCTC 13352, E. coli NCTC 13353 and E. coli NCTC 10418 (HPA culture collections) were used for control purposes.
Detection of vancomycin-resistant enterococci, meticillinresistant Staphylococcus aureus (MRSA) and Panton-Valentine leukocidin (PVL) producing S. aureus. A published protocol (Jayaratne & Rutherford, 1999 ) was used to screen all Enterococcus faecalis and Enterococcus faecium isolates for the presence of vanA and vanB genes. GenElute extraction kits (Sigma) were used to extract bacterial genomic DNA. Enterococcus faecalis NCTC 12201 was used as a reference strain.
A real-time PCR protocol developed by Thomas et al. (2007) was used to detect the presence of the mecA gene, which confers resistance to meticillin, in all S. aureus isolates. PCR was also performed for the detection of the PVL-encoding gene, lukF, using a published protocol (Ribeiro et al., 2005) . The BSAC disc diffusion protocol (Andrews, 2009 ) was followed to test all S. aureus isolates for phenotypic resistance to cefoxitin, which is indicative of meticillin resistance, and a selection of Enterococcus isolates for phenotypic resistance to vancomycin.
BOX-PCR. To confirm the organisms isolated from the UTI cultures were not all related to a single locally disseminated clone, BOX-PCR was performed using a protocol adapted from that of Koeuth et al. (1995) . Extraintestinal pathogenic E. coli (ExPEC) CFT073 was used as a reference strain. PCR products were examined using BioNumerics v. 3.5 software (Applied Maths), using CFT073 to monitor the repeatability of the experiment.
Cell cultures. T24 human epithelial cells (HPA cultures) were grown in McCoy's 5A modified media (Sigma) supplemented with 10 % fetal bovine serum (Sigma) and 0.75 % L-glutamine (Sigma). Cells were grown in an atmosphere with 5 % CO 2 at 37 uC and subcultured twice weekly. Two days prior to cell infection assays, the T24 cells were seeded into 24-well plates.
Association and invasion assays. All E. coli assays were performed in duplicate on different days, and in triplicate wells in each assay. Bacteria were cultured overnight in Luria-Bertani broth, harvested by centrifugation and resuspended in supplemented tissue culture medium, which was then adjusted to 2610 7 c.f.u. ml
, giving an m.o.i. of 1 : 100. For E. coli, all 129 polymicrobial ExPEC and 21 monomicrobial ExPEC isolated in this study were quantifiably assayed using classical gentamicin protection assays as described previously (McNally et al., 2007) , using cultured T24 bladder cells. The invasive ExPEC type strain, CFT073, was used as a positive control strain in all assays, and E. coli DH5a was used as a negative control strain. The mean number of invasive bacteria was determined by the Miles and Misra plate count method from triplicate wells. Strains that showed more than a 10-fold increase in invasion compared to CFT073 were classed as highly invasive strains. Those that showed more than a 10-fold decrease in invasion compared to CFT073 were deemed to be strains of limited invasive potential.
All Enterococcus faecalis, Proteus mirabilis, P. aeruginosa and S. aureus were subjected to a semiquantitative screen performed in triplicate on different days to assess levels of invasion. Assays were completed using the above method, which was adapted for 96-well plates as described by Javed et al. (2010) .
Statistical analysis. x
2 tests were performed to compare invasion and antimicrobial resistance between the monomicrobial culture and mixed culture populations, and also bacterial prevalence in different patient groups.
RESULTS
Similar bacterial species are isolated from monomicrobial and polymicrobial UTI samples Urine culture plates were collected from 250 patients over a 9 month period from NUH, and were taken from both hospitalized and community patients, with the median age of patients being 83.5 years. Of the 200 polymicrobial cultures collected, 71 (35.5 %) contained 2 organisms, 90 (45 %) contained 3 organisms, 36 (18 %) contained 4 organisms and 3 (1.5 %) contained 5 organisms. A total of 83 patients (33 %) had a previous history of UTI, 27 cases of which were designated 'mixed' by the NUH clinical laboratory. Of these 27 patients presenting with a polymicrobial UTI, 13 went on to have further incidences of polymicrobial UTI after this study, 5 patients went on to have a UTI sample with a confirmed organism in monomicrobial culture and 9 had no further infections.
A total of 621 bacterial strains were isolated from the 250 urine cultures and identified to the species level using API identification systems (Fig. 1) . The most predominant organism in both catheterized and uncatheterized patients was E. coli, which was also far more prevalent in female patient cultures (83 %) than male cultures (46 %) (P,0.001). In male samples Enterococcus faecalis was equally as ubiquitous as E. coli. These two organisms were also frequently associated in mixed cultures (36 %). E. coli was isolated from 68 % of polymicrobial cultures and 48 % of monomicrobial cultures, and Enterococcus faecalis was isolated from 55 % of polymicrobial cultures, but was significantly less frequently isolated from monomicrobial cultures (8 %) (P,0.001). P. aeruginosa, Proteus mirabilis and S. aureus were also frequently isolated from 23, 25 and 10.5 % of polymicrobial cultures, respectively.
BOX-PCR profiles provide evidence of a genetically diverse population
In order to ensure that the organisms isolated were not epidemic clones, the clonal relatedness of E. coli, Enterococcus faecalis, Proteus mirabilis, P. aeruginosa and S. aureus isolates was determined by BOX-PCR. BOX-group numbers were allocated based upon a similarity threshold of 92 %, which was decided upon after reviewing other publications (Proudy et al., 2008; Yang et al., 2004) . The E. coli strains exhibited varying BOX profiles (Fig. 2) and did not appear to belong to a dominant epidemic clone. Nineteen distinct clonal groups of E. coli were assigned, the largest of which encompassed 71 of the total 150 E. coli strains in the collection. Eleven distinct BOX groups of Enterococcus faecalis were detected, with the majority of isolates belonging to two of the groups, group 1 containing 53 isolates and group 3 containing 37 isolates. A total of 18 of the 51 P. aeruginosa isolates were deemed to belong to the same BOX group, and other isolates were also allocated to 11 other BOX groups. Proteus mirabilis were allocated to five BOX groups in total, with 88 % of strains found to belong to a single BOX group. S. aureus were allocated to seven BOX groups with 50 % of the total strains belonging to one group. These results suggest that the isolates are not derived from a single epidemic clone of each species, and are indeed individual strains that could reasonably be expected to possess varying phenotypic and genotypic properties.
Antibiotic resistance is comparable between bacteria from mixed and monomicrobial cultures
To determine the specific antibiotic resistances within the population of polymicrobial UTI organisms, 394 isolates of the 5 most commonly isolated species (E. coli, Enterococcus faecalis, P. aeruginosa, Proteus mirabilis and S. aureus) were subjected to antibiotic susceptibility tests using an antibiotic panel presently used in the NUH clinical laboratory (Table 1 ). The results suggest that bacteria isolated from mixed culture samples exhibit comparable levels of resistance to front-line antibiotics as that observed in isolates from monomicrobial culture samples, regardless of species. With respect to E. coli, the percentage of mixed culture sample isolates exhibiting resistance to ciprofloxacin and trimethoprim was higher than that observed in monomicrobial culture sample isolates, and also higher than the levels observed routinely in clinical UTI isolates. The differences observed in this study are not statistically significant but require further specific investigation.
Increased detection of ESBLs in monomicrobial culture isolates
Due to the increasing prevalence of ESBLs in clinical samples, the UTI isolates were screened both for the possession of b-lactamase-encoding genes and also for any ESBL phenotypic activity. All E. coli, Enterobacter, Citrobacter, Klebsiella, Proteus and Pseudomonas strains (n5355) were screened for the presence of bla TEM , bla SHV , bla CTX-M , and bla OXA genes using a published protocol (Fang et al., 2008) . Forty-nine per cent of strains were found to possess a b-lactamase-encoding gene, and one fifth of the strains possessed multiple bla genes (Table 2) . Interestingly most of the strains containing multiple b-lactamases originated from monomicrobial culture infections (P50.009). Klebsiella species were found to possess the most b-lactamases (93 % positive), 61 % of E. coli also possessed a form of b-lactamase and 12 % possessed multiple b-lactamase-encoding genes. The ESBL CTX-M was found significantly more frequently in monomicrobial culture isolates than in isolates from polymicrobial infections (P50.014). To determine the phenotypic expression of extended-spectrum resistance against b-lactam antibiotics the double-disc method was used to screen all 173 blactamase PCR-positive strains. A total of 16 strains (9 %) exhibited phenotypic ESBL activity (12 E. coli, 3 Pseudomonas and 1 Enterobacter), most of which was in strains that possessed multiple b-lactamase-encoding genes, making it impossible to identify the b-lactamase-encoding gene responsible for the extended-spectrum resistance.
Detection of MRSA and PVL-producing S. aureus in polymicrobial UTI samples PCR detection of the mecA gene, confirmed 10 (45 %) of the urinary S. aureus isolates to be MRSA. One of these was isolated from a monomicrobial culture UTI, and the remaining nine confirmed MRSA were isolated from polymicrobial UTI samples. Phenotypic resistance tests confirmed all PCR MRSA strains to be resistant to cefoxitin, which is an indicator of meticillin resistance. The lukF gene, which encodes PVL, was detected in two meticillin-sensitive S. aureus strains, which were both isolated from polymicrobial UTI samples. No vancomycin resistance genes were found in any of the Enterococcus faecalis isolates, but vanA was found in one Enterococcus faecium isolate. This isolate did not however show any phenotypic resistance to vancomycin.
Bacteria isolated from polymicrobial UTI samples exhibit increased pathogenic potential in in vitro cell invasion assays
The ability to invade host epithelial cells is a critical factor in UTI. Therefore, all E. coli, Enterococcus faecalis, P. aeruginosa, Proteus mirabilis and S. aureus strains were investigated to determine their ability to invade a human uroepithelial cell line. T24 human bladder cells were infected with a bacterial culture for 3 h, after which external bacteria were killed by the addition of gentamicin and internalized bacteria were enumerated. In the case of the E. coli assays, strains were designated highly invasive if they showed a 10-fold increase in invasiveness compared to that of the invasive reference strain, E. coli CFT073, which exhibited variation of less than 1 log across all assays performed (less than 10-fold). Overall 52 strains (34.7 %) were seen to exhibit the highly invasive phenotype and 21 strains (14 %) exhibited a low invasive phenotype, more than a 10-fold reduction in invasion compared to CFT073. E. coli isolates from mixed culture samples exhibited increases in invasion as great as 1000-fold higher than that observed in the invasive type strain CFT073. No invasive capacity was observed in five strains, of which three were isolated from monomicrobial culture samples where they were reported as the infectious agent. Overall 45 % of the polymicrobial E. coli strains assayed invaded to a similar level (less than a 10-fold increase or decrease) as CFT073 (Fig. 3 ). This is not significantly different to the monomicrobial culture isolates, 62 % of which showed similar invasion capability to CFT073. In contrast 44 % of polymicrobial E. coli strains were highly invasive, whereas no monomicrobial culture isolates invaded to a greater level than CFT073 and 11 % of polymicrobial isolates were classified as 'low invasive' compared to 38 % of monomicrobial culture isolates. This suggests that E. coli isolated from polymicrobial UTI samples may be significantly more invasive (P,0.001, x 2 distribution of strains with high, normal and low invasive capacity across polymicrobial and monomicrobial populations) in an in vitro uroepithelial cell infection model, than E. coli isolated as monomicrobial cultures from UTI samples. No association could be found between invasiveness and patient gender, previous history of UTI, catheterization status, health status of the patient, antibiotic resistance profile or BOX-PCR group.
Invasion assays were also performed on all Enterococcus faecalis, Proteus mirabilis, P. aeruginosa and S. aureus isolates. A wide range in invasion capability was noted in Enterococcus faecalis isolates, ranging from 10 6 to 10 2 c.f.u. bacteria ml 21 recovered from invasion assays. Proteus mirabilis, P. aeruginosa and S. aureus showed a similar trend with a 3-log range in invasion. Similarly the increased/decreased invasion levels were not attributable to any patient characteristic, antibiotic resistance profile or BOX-PCR group.
DISCUSSION
UTI rates in elderly people in the community can be as high as 10 % at any one time, and this figure can rise to 30 % for hospitalized patients. Bacteraemic UTIs in elderly patients can result in sepsis and death (Cove-Smith & Almond, 2007) . A clinical microbiology laboratory will not routinely pursue or report organisms present in mixed culture from urine samples unless there is a significant count of a predominant organism. As up to 33 % of samples can be polymicrobial a large proportion of infections from the elderly population may go untreated or indeed be treated with inappropriate antibiotics. This will only serve to encourage the development of antibiotic resistance in urinary pathogens.
The predominant organism in polymicrobial UTI samples was E. coli, which concurs with the general consensus among published data concerning monomicrobial culture UTIs (Farajnia et al., 2009; Tal et al., 2005; Johnson, 1991; Brzuszkiewicz et al., 2006) . Enterococcus faecalis was the second most commonly isolated organism, and was significantly more prevalent in polymicrobial cultures than monomicrobial cultures (P,0.001). Enterococcus faecalis and E. coli were found together in 36 % of cultures, and coinfection by these two pathogens may pose important questions for the antibiotic treatment of polymicrobial UTI as Enterococcus is known to be intrinsically resistant to many antibiotics, including several first-choice antibiotics for the treatment of UTI. The presence of both Enterococcus faecalis and uropathogenic E. coli in an infection not only may create difficulties in devising an antibiotic treatment regimen but also may exacerbate the pathogenicity of the E. 
coli, as recent studies have suggested (Lavigne et al., 2008; Montravers et al., 1997) .
Prescription of ineffective antibacterial agents can increase the selection pressure for antibiotic-resistant agents within an infection. Organisms present in polymicrobial UTI cultures, that would not routinely be investigated, possessed antibiotic resistance to front-line antibiotics such as trimethoprim, ciprofloxacin and amoxicillin. More importantly, the percentage of mixed culture sample E. coli isolates exhibiting resistance to trimethoprim and ciprofloxacin was higher than that observed in monomicrobial culture sample isolates, and also higher than the levels observed routinely in clinical isolates. Another issue raising concerns for patient health is the presence of MRSA and PVL-producing meticillinsensitive S. aureus in polymicrobial UTI samples, which would not be detected under the current guidelines for UTI diagnosis. The presence of MRSA in an infection limits the choice of antibiotics available for treatment, and the cytotoxin PVL attacks white blood cells and can cause severe tissue necrosis (Holmes et al., 2005) . Other specific antibiotic-resistance traits were also detected, such as ESBLs, by PCR for known b-lactamase-encoding genes, although only a small proportion showed phenotypic activity. This discrepancy re-emphasizes the importance of screening clinical isolates for ESBL gene carriage as opposed to phenotypic tests (Livermore & Hawkey, 2005; Tofteland et al., 2007; Xu et al., 2005) . Interestingly, the current increase in isolation of E. coli 025b-ST131 CTX-M R from clinical samples (Lau et al., 2008; Nicolas-Chanoine et al., 2008; Vincent et al., 2010) does not appear to be reflected in this study, with only 11 % of E. coli containing the bla CTX-M gene. The full genetic diversity and lineage of the ExPEC strains isolated in this study is the current focus of intensive research.
It has been suggested that the critical step in UTI initiation is the attachment to and invasion of the superficial bladder epithelium, especially in the case of E. coli (Anderson et al., 2003; Mulvey et al., 2001) . By attaching to bladder epithelial cells E. coli are able to establish reservoirs known as intra-cellular bacterial communities, from which the invading bacteria receive some level of protection against the host immune system and also initiate recurrent infections. Therefore, invasive bacteria are considered more proficient in instigating an infection. Significant differences were identified in the invasive capabilities of monomicrobial culture and polymicrobial culture isolates (Fig. 3 ). E. coli isolates of polymicrobial culture origin were significantly more invasive, when compared to the invasion of the type strain E. coli CFT073, than strains isolated from monomicrobial culture samples. The majority of isolates from monomicrobial infections were less invasive than E. coli CFT073 and none exhibited a highly invasive phenotype. The polymicrobial isolates that possessed increased invasive capacity did not belong exclusively to any specific patient group and were not shown to be associated with patient gender, catheterization status, previous history of UTI and underlying medical issues, antibiotic resistance profile or BOX-PCR group. This indicates the potential existence of a heterogeneous group of highly invasive E. coli within polymicrobial UTIs in the elderly, which would not be diagnosed or treated due to limitations in the current diagnostic standard procedure. A further study including larger numbers of ExPEC isolates from monomicrobial infections is required to rule out any such associations, and indeed to confirm the significance of the increased invasive phenotype exclusively observed in the polymicrobial isolates from this study. This is currently under investigation in several hospital laboratories examining equal numbers of polymicrobial and monomicrobial isolates, including an examination of the clinical nature of the infections, their association with complicated or uncomplicated UTI, and the genotypic and phenotypic differences associated with the hyper-invasive phenotype.
The frequent co-isolation of E. coli and Enterococcus faecalis from the clinical UTI samples raises questions as to the possible contribution of enterococci to the increased invasive phenotype expressed by the ExPEC strains isolated in this study. There have been reports of enterococci exacerbating the pathogenicity of other organisms including ExPEC in both C. elegans and rat models of infection (Lavigne et al., 2008; Montravers et al., 1997) , and the promiscuous nature of enterococci with regard to gene transfer is well known. The possibility that enterococci can alter the genotype and/or phenotype of ExPEC during coinfection of bladder epithelial cells is currently the subject of further investigation.
Polymicrobial UTIs may pose a heightened threat to the health and well being of the elderly population. This study found that the organisms present in polymicrobial UTIs possess traits such as antibiotic resistance akin to that of their monomicrobial culture counterparts, and potentially with increased resistance to ciprofloxacin and trimethoprim, which are common front-line antibiotics used for UTI treatment. Due to the complexities involved in the diagnosis and treatment in these infections many patients may receive inadequate antibiotic treatment or indeed a lack of treatment altogether. More worryingly for patient health, the majority of organisms isolated from polymicrobial cultures also exhibited increased human pathogenic potential as evidenced by in vitro cell infection assays. The diagnostic standard procedure for UTI should be reconsidered in light of the data presented here.
